Scope International AG has announced the appointment of Andrew Bradshaw as the new UK Managing Director for its subsidiary, based in Manchester, UK. Guiding a highly motivated and qualified team, Andrew will be responsible for the strategic development of Scope International (UK) Ltd.
Graduated in Biomedical Sciences from University of Manchester, Andrew started his career at a large clinical research organisation. His work as clinical research associate provided him with a strong background in monitoring clinical studies and laid the ground for his further career.
In 2016, Andrew joined Scope International AG, where he gained solid skills by working in the fields of regulatory affairs and clinical operations. With the appointment of Managing Director, he will continue to use his high qualifications and business experiences to continuously develop and implement new strategic ideas.
“I am proud to have been appointed as general manager of Scope UK, we have a great base in the UK and Scope International are in an excellent position for growth, both globally and in the UK. I am truly excited to be on board with such a great team.”
Scope’s UK office was opened in 2013. Since then, we built a team of Monitoring and Project Management staff in Bolton, Greater Manchester. We offer the ability to manage our local UK and Ireland projects and internationally in collaboration with a large multidisciplinary team distributed in different offices of the company.
Scope International AG is pleased to announce the appointment of Amy O’Sullivan as the new Managing Director of its North American subsidiary, based in Pittsburgh, Pennsylvania. Guiding SCOPE’s business in our fastest growing market, Amy will take over an essential part of our strategic development and leading a growing team.
Amy is a board-registered nurse with bachelor’s degrees in both chemistry and nursing. With more than a decade of experience in clinical research across varied and complex indications, she has a proven track record of leading and motivating national and international teams to deliver quality projects on time. She has solid skills in the field of project management, clinical operation and strategic planning experience at the site, sponsor, and CRO setting. Her indications experience includes hematology, oncology, nephrology, cardiology, women’s health, neurology, and pain.
Amy has grown with the company and seamlessly steps into the role of leading Scope International’s North American operations.
“I am excited to head Scope International’s US office and am looking forward to expanding our clinical research services in the North American market.”
Our experienced local US team will give you regulatory support during pre-IND, IDE, de novo, and other formal meetings, as well as scientific advice with the FDA. Our experts will accompany your complete submission process in the US and Canada.
SCOPE’s Pittsburgh office covers 25 US states, Toronto and Montreal, while other US states along with the Mexico and Puerto Rico regions are covered by strategic satellite offices in the South, Southwest, Pacific Northwest and Western regions of the US.
NewsNew Managing Director for North American Operations
Our clinical trial management system InSIGHT now has an electronic signature feature which allows you to sign and authorize study documents more quickly. This new, easy to use feature allows for controlled, accelerated collection of multiple signatures on one document.